Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease
暂无分享,去创建一个
A. Lawrence | A. Lees | A. Evans | S. Appel | J. Potts | A. J. Lees | Jay D. Potts
[1] J. Régis,et al. Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation , 2005, Movement disorders : official journal of the Movement Disorder Society.
[2] Erwan Bezard,et al. Involvement of Sensorimotor, Limbic, and Associative Basal Ganglia Domains in L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia , 2005, The Journal of Neuroscience.
[3] Andrew Evans,et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges , 2005, Movement disorders : official journal of the Movement Disorder Society.
[4] C. Colosimo,et al. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[5] A. Lees,et al. Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study. , 2004, Drug and alcohol dependence.
[6] Nora D. Volkow,et al. The reality of comorbidity: Depression and drug abuse , 2004, Biological Psychiatry.
[7] Ladislav Hosák,et al. Temperament and character inventory (TCI) personality profile in metamphetamine abusers: a controlled study , 2004, European Psychiatry.
[8] Regina Katzenschlager,et al. Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome , 2004, Movement disorders : official journal of the Movement Disorder Society.
[9] L. Parsons,et al. Neurobiological mechanisms in the transition from drug use to drug dependence , 2004, Neuroscience & Biobehavioral Reviews.
[10] M. Moal,et al. Repeated stress increases locomotor response to amphetamine , 2004, Psychopharmacology.
[11] C. Lerman,et al. Which Adolescents Are Most Receptive to Tobacco Industry Marketing? Implications for Counter-Advertising Campaigns , 2003, Health communication.
[12] A. Lawrence,et al. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? , 2003, The Lancet Neurology.
[13] JaneR . Taylor,et al. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. , 2003, The American journal of psychiatry.
[14] Sheri L. Johnson,et al. BIS/BAS Levels and Psychiatric Disorder: An Epidemiological Study , 2003 .
[15] R. Malenka,et al. Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons , 2003, Neuron.
[16] N. el-Guebaly,et al. Relationship between craving and personality in treatment-seeking women with substance-related disorders , 2003, BMC psychiatry.
[17] A. Dagher,et al. Amphetamine-Induced Increases in Extracellular Dopamine, Drug Wanting, and Novelty Seeking: A PET/[11C]Raclopride Study in Healthy Men , 2002, Neuropsychopharmacology.
[18] D. Burn. Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[19] L. Donohew,et al. Television campaigns and adolescent marijuana use: tests of sensation seeking targeting. , 2001, American journal of public health.
[20] J. Gray,et al. Dopamine, appetitive reinforcement, and the neuropsychology of human learning: An individual differences approach , 2001 .
[21] R. Cantello. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies , 2000, Journal of neurology, neurosurgery, and psychiatry.
[22] K. Sher,et al. Personality and substance use disorders: a prospective study. , 2000, Journal of consulting and clinical psychology.
[23] G. Wardeh,et al. Unrestricted free-choice ethanol self-administration in rats causes long-term neuroadaptations in the nucleus accumbens and caudate putamen , 1999, Psychopharmacology.
[24] K. Hornik,et al. The Tridimensional Personality Questionnaire as a predictor of relapse in detoxified alcohol dependents. The European Fluvoxamine in Alcoholism Study Group. , 1999, Alcoholism, clinical and experimental research.
[25] A. Phillips,et al. Facilitation of sexual behavior in male rats following d-amphetamine-induced behavioral sensitization , 1999, Psychopharmacology.
[26] G. Phillips,et al. Enhanced appetitive conditioning following repeated pretreatment with d-amphetamine. , 1998, Behavioural pharmacology.
[27] G. Brannigan,et al. Experiences in Personality: Research, Assessment, and Change , 1997 .
[28] C. R. Cloninger,et al. Relationships between Cloninger's, Zuckerman's, and Eysenck's dimensions of personality. , 1996, Personality and individual differences.
[29] M. Bardo,et al. Psychobiology of novelty seeking and drug seeking behavior , 1996, Behavioural Brain Research.
[30] C. Carver,et al. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS Scales , 1994 .
[31] M. Zuckerman. Behavioral Expressions and Biosocial Bases of Sensation Seeking , 1994 .
[32] C. R. Cloninger,et al. A psychobiological model of temperament and character. , 1993, Archives of general psychiatry.
[33] R. Pihl,et al. Factor structure and correlates of the Tridimensional Personality Questionnaire. , 1992, Journal of studies on alcohol.
[34] E. Rimm,et al. The assessment of alcohol consumption by a simple self-administered questionnaire. , 1991, American journal of epidemiology.
[35] C. Robert Cloninger,et al. Childhood personality predicts alcohol abuse in young adults. , 1988, Alcoholism, clinical and experimental research.
[36] C. Robert Cloninger,et al. Neurogenetic adaptive mechanisms in alcoholism. , 1987, Science.
[37] A. Logue,et al. Predictors of food preferences in adult humans , 1986, Appetite.
[38] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.